Athira Pharma, Inc. - ATHA

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Biological Products, (no Disgnostic Substances)
Latest data: 12/20/2024 10:22:22 PM
EDGAR CIK 0001620463

Buy Breakdown

Total $100,051

Sell Breakdown

Total $46,454

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
09/05/2024
09/05/2024
Church Kevin
CHIEF SCIENTIFIC OFFICER
Officer
Sell
-2,525 @ $0.57
($1,429.15)
 92,684 (-2.65%) Direct
09/05/2024
09/05/2024
Gengos Andrew
CFO and Chief Business Officer
CFO
Sell
-1,272 @ $0.57
($719.95)
 97,532 (-1.29%) Direct
09/05/2024
09/05/2024
Lenington Rachel
COO and CDO
Officer
Sell
-2,525 @ $0.57
($1,429.15)
 20,870 (-10.79%) Direct
09/05/2024
09/05/2024
Litton Mark James
President and CEO
CEO Director
Sell
-5,032 @ $0.57
($2,848.11)
 159,365 (-3.06%) Direct
09/05/2024
09/05/2024
Worthington Mark
GENERAL COUNSEL
Officer
Sell
-2,525 @ $0.57
($1,429.15)
 51,927 (-4.64%) Direct
06/24/2024
06/25/2024
Romano Kelly A
Director
Buy
27,400 @ $2.42
$66,179.22
 80,715 (51.39%) Direct
06/21/2024
06/25/2024
Romano Kelly A
Director
Buy
15,000 @ $2.26
$33,871.50
 53,315 (39.15%) Direct
01/05/2024
02/16/2024
Church Kevin
CHIEF SCIENTIFIC OFFICER
Officer
Sell
-2,412 @ $2.91
($7,018.92)
 80,256 (-2.92%) Direct
01/05/2024
02/16/2024
Gengos Andrew
CFO AND CHIEF BUSINESS OFFICER
CFO
Sell
-1,208 @ $2.91
($3,515.28)
 83,804 (-1.42%) Direct
01/05/2024
02/16/2024
Lenington Rachel
COO AND CDO
Officer
Sell
-2,412 @ $2.91
($7,018.92)
 13,395 (-15.26%) Direct
01/05/2024
02/16/2024
Litton Mark James
CEO
CEO Director
Sell
-4,820 @ $2.91
($14,026.20)
 144,397 (-3.23%) Direct
01/05/2024
02/16/2024
Worthington Mark
GENERAL COUNSEL
Officer
Sell
-2,412 @ $2.91
($7,018.92)
 34,452 (-6.54%) Direct